Delivery Order SPE2DB24D2105-SPE2DB25FAPVL
Award Date 6/26/25
Potential Completion Date 6/27/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $16,413.14 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes treatment medication. The contract has a completion date of June 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $4,975.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication. The contract is not set-aside and has an ultimate completion date of July 3, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a $1,611.96 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication, with a performance period through June 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a comprehensive global pharmaceutical support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,005.10 contract is for the supply of 4,568,093,505 units of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes treatment medication. The contract has a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This is a $5,976.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a period of performance through June 17, 2025. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This is a $9,278.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is to supply 4568535145 NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes treatment medication, with a completion date of June 13, 2025. The award is not associated with a set-aside contract vehicle. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a $1,555.92 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication. The contract is a firm fixed-price delivery order with a completion date of June 16, 2025. It is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a $5,405.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used in the treatment of diabetes. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
- This is a delivery order under contract SPE2DX15D1053|SPE2DX25F6NKS, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,852.98 firm-fixed-price contract is for the delivery of 4,568,202,798 units of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication. The award is not set aside and has a performance period through May 12, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes treatment medication, with a ceiling value of $15,765.12 and a performance period ending on May 1, 2025. The contract is not set aside and was awarded on April 30, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a...